LEXICON PHARMACEUTICALS INC
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
LXRX$1.82+2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except par value and share amounts)
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $22,465 | $46,345 |
| Short-term investments | 147,561 | 92,012 |
| Accounts receivable, net | 1,010 | 28 |
| Inventory | 381 | — |
| Prepaid expenses and other current assets | 5,130 | 2,481 |
| Total current assets | 176,547 | 140,866 |
| Property and equipment, net of accumulated depreciation and amortization of $4,538 and $3,984, respectively | 1,987 | 2,071 |
| Goodwill | 44,543 | 44,543 |
| Operating lease right-of-use-assets | 5,524 | 6,407 |
| Other assets | 828 | 412 |
| Total assets | $229,429 | $194,299 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $14,389 | $10,395 |
| Accrued liabilities | 17,157 | 12,777 |
| Total current liabilities | 31,546 | 23,172 |
| Long-term debt, net | 99,508 | 48,579 |
| Long-term operating lease liabilities | 5,265 | 5,424 |
| Total liabilities | 136,319 | 77,175 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' Equity: | ||
| Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 300,000,000 shares authorized; 245,792,668 and 189,213,948 shares issued, respectively | 245 | 189 |
| Additional paid-in capital | 1,862,558 | 1,709,144 |
| Accumulated deficit | (1,766,839) | (1,589,720) |
| Accumulated other comprehensive income (loss) | 31 | (428) |
| Treasury stock, at cost, 867,973 and 488,205 shares, respectively | (2,885) | (2,061) |
| Total stockholders' equity | 93,110 | 117,124 |
| Total liabilities and stockholders’ equity | $229,429 | $194,299 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.